Inducible Toll-like receptor and NF-kappaB regulatory pathway expression in human adipose tissue - Wikidata - awgldk - TriplyDB

Inducible Toll-like receptor and NF-kappaB regulatory pathway expression in human adipose tissue

Inducible Toll-like receptor and NF-kappaB regulatory pathway expression in human adipose tissue

http://www.wikidata.org/entity/Q35688789

about

Effect of elevated carbon dioxide on bronchial epithelial innate immune receptor response to organic dust from swine confinement barns Age-associated increase in cytokine production during systemic inflammation: adipose tissue as a major source of IL-6 Impact of increased adipose tissue mass on inflammation, insulin resistance, and dyslipidemia Obesity-Driven Gut Microbiota Inflammatory Pathways to Metabolic Syndrome The Impact of Vitamin D Levels on Inflammatory Status: A Systematic Review of Immune Cell Studies Mechanisms and metabolic implications of regional differences among fat depots The beneficial role of vitamin D in obesity: possible genetic and cell signaling mechanisms Adipokines and the role of visceral adipose tissue in inflammatory bowel disease Nutrient sensing and inflammation in metabolic diseases.Corticotrophin-Releasing Factor (CRF) and the urocortins are potent regulators of the inflammatory phenotype of human and mouse white adipocytes and the differentiation of mouse 3T3L1 pre-adipocytes.Signaling pathways involved in LPS induced TNFalpha production in human adipocytes.Relationship between adipose tissue dysfunction, vitamin D deficiency and the pathogenesis of non-alcoholic fatty liver disease.Immature myeloid cells induced by a high-fat diet contribute to liver inflammation.Toll-like receptor 4 (TLR4) expression in human and murine pancreatic beta-cells affects cell viability and insulin homeostasis.Release of inflammatory mediators by human adipose tissue is enhanced in obesity and primarily by the nonfat cells: a review.Effect of simvastatin on burn-induced alterations in tissue specific glucose metabolism: implications for burn associated insulin resistance.The role of adipose tissue and adipokines in obesity-related inflammatory diseases TLR4 and Insulin Resistance.CD14 deficiency impacts glucose homeostasis in mice through altered adrenal tone.Fat tissue, aging, and cellular senescence.B lymphocytes in human subcutaneous adipose crown-like structures TLR2 stimulation induces cardiac inflammation but not cardiac depression in vivo.Aging and regional differences in fat cell progenitors - a mini-review.NLRP3 inflammasomes link inflammation and metabolic disease.The chaperone balance hypothesis: the importance of the extracellular to intracellular HSP70 ratio to inflammation-driven type 2 diabetes, the effect of exercise, and the implications for clinical management.Mesenteric fat as a source of C reactive protein and as a target for bacterial translocation in Crohn's disease.Much More than M1 and M2 Macrophages, There are also CD169(+) and TCR(+) Macrophages.Fractalkine is a novel human adipochemokine associated with type 2 diabetes Effect of lipopolysaccharides on adipogenic potential and premature senescence of adipocyte progenitors.Age-Associated Increase in Cytokine Production During Systemic Inflammation-II: The Role of IL-1β in Age-Dependent IL-6 Upregulation in Adipose Tissue Radiolucency below the crown of mandibular horizontal incompletely impacted third molars and acute inflammation in men with diabetes.The microbiome extends to subepidermal compartments of normal skin.IGF-I attenuates FFA-induced activation of JNK1 phosphorylation and TNFα expression in human subcutaneous preadipocytes Effects of exercise and low-fat diet on adipose tissue inflammation and metabolic complications in obese mice.Effects of diet and exercise on metabolic disturbances in high-fat diet-fed mice.Gene profiling of human adipose tissue during evoked inflammation in vivo.Mechanisms of obesity and related pathology: linking immune responses to metabolic stress.Effects of an Encapsulated Fruit and Vegetable Juice Concentrate on Obesity-Induced Systemic Inflammation: A Randomised Controlled Trial.microRNAs as a new mechanism regulating adipose tissue inflammation in obesity and as a novel therapeutic strategy in the metabolic syndrome.Extraluminal factors contributing to inflammatory bowel disease

P2860

Q23911485-C7D03AD0-F937-4AC6-A0F9-7D9662A2EB9F Q24616666-2FAE4688-1C79-4F2C-95AA-B13BD5D9CD02 Q24645182-DAA51C1A-4F07-4395-8DBD-343BF5FF8EAB Q26774779-057E6602-14C4-430D-8134-FA02BE9AFE84 Q26777083-F93327CE-54C8-4312-9653-E79BD8E573AA Q27004113-2500EFDA-6B96-45A7-960A-7ADAB91DCF27 Q27021538-CD7AEF66-B3C0-4E82-9241-39F1280673A3 Q28070229-DCCFFB7E-7E6B-4DA5-B586-2C311432A4F0 Q33623354-E70019A9-587D-4AE5-9E60-26F9B80B9551 Q33623899-EE045826-B207-452F-9398-D2D622CF1DED Q33645157-90A58C58-F64C-4AB2-B002-379D1491DA84 Q33719929-DD37783F-80D2-43BA-8DA1-82264365AA8B Q33781288-D92DB0EC-7B87-4F30-8598-031364691DFC Q33830986-C9BD94E1-9DF0-41E8-AE51-D07180370808 Q33870787-42C03F02-A240-46D4-96C1-B93144FE557D Q33876511-C96D36C5-4298-4F53-9F1B-DE444B6C0E20 Q34022211-5FC1B076-D38E-452E-AC6E-88AED8485C68 Q34097407-18F04A60-3429-4C67-9C78-624005FE3C48 Q34130570-DE8C62D1-0128-40B0-9097-8D6862925549 Q34130783-B6884BD8-97FD-46FB-A235-5387765F92E6 Q34186722-1A501A00-C35B-4F05-BA43-338F26E0AD40 Q34255776-6CC7D04A-EFFC-49CE-98AF-2F28FD8114AC Q34540615-04F21A8A-4DA8-4090-A2C0-A7106771408F Q35151726-9837A0EB-01A6-4206-AFA0-390F1798A95C Q35169987-D63951AA-23C2-4306-BBFA-E26C8CE45BA0 Q35593129-47C3034B-635D-49EE-A98E-97DD9CEB2131 Q35646486-81B6BCA1-084F-4CD8-B252-646DD4DA4A12 Q35796996-F651816B-24E4-430B-83AF-CFC92E9CF75C Q35958518-F6A4F4BB-D1ED-4CB5-AB6A-CA141C2D9BA6 Q36276463-55E82F6A-DAD2-4FF6-83B5-18F76385A281 Q36838801-D50A7CD2-6421-4522-862E-256A3E7EB3E3 Q36848980-779A8C50-97AF-497F-AB1F-DE91439C7CE4 Q36948274-14D8CECB-6AFA-4D28-A94C-6C4C07490202 Q37190086-99D03AFA-0602-4F0B-AC53-DDCAA1305FF3 Q37345631-C03E6682-D260-4E77-A5F7-0CBEBD4DA2F2 Q37360466-0B490BE0-125B-495A-BA50-2DD8323D624B Q37597595-C3839706-39EB-4854-B140-AA65E0500B40 Q37673154-890D3BCB-0CEE-41F9-A2E4-206898571B2E Q37704979-4C0FF78D-5476-4213-8C20-1160FE0A3658 Q37847061-EAB600E8-A30D-4DE0-910D-7D9E85149F54

P2860

Inducible Toll-like receptor and NF-kappaB regulatory pathway expression in human adipose tissue

http://www.wikidata.org/entity/Q35688789

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Inducible Toll-like receptor a ...... ession in human adipose tissue

@ast

Inducible Toll-like receptor a ...... ession in human adipose tissue

@en

type

label

Inducible Toll-like receptor a ...... ession in human adipose tissue

@ast

Inducible Toll-like receptor a ...... ession in human adipose tissue

@en

prefLabel

Inducible Toll-like receptor a ...... ession in human adipose tissue

@ast

Inducible Toll-like receptor a ...... ession in human adipose tissue

@en

P1433

Q35688789-B707BEE4-13C3-4576-AD57-7E89AA0444B5

P1476

Q35688789-5B401DC8-94C3-4987-A119-A622577B80DD

P2093

Q35688789-417D31A8-B1BA-4C14-9530-0647B800E62F

Q35688789-53427280-55A7-4079-80AA-11FDC2405CBB

Q35688789-6546967E-EA30-4C2B-9A5E-6AC2D8EB45A1

Q35688789-6D3D37FC-0C4B-46F1-9BEA-1BB0991875D8

Q35688789-A74EE44B-4D48-4BC1-A2CC-10999821285A

Q35688789-EF22F6E7-1C77-446D-981B-6BF17C82FD61

P2860

Q35688789-0B29693F-1192-48CC-9C1B-C425A470631A

Q35688789-1993E9EB-EF49-4715-A56D-3B02D6571F75

Q35688789-1F73E9E4-455F-486C-AB7F-0AF0F2A0132F

Q35688789-2036BEF0-18C2-4844-93DF-95883D362868

Q35688789-2BDCC2E0-7ABF-41C8-BA49-0250609EA5AD

Q35688789-3F6FD54E-0F1E-4A9B-8C5F-421EBBF91976

Q35688789-42F0D040-1404-4B8C-A489-F69A794D77AD

Q35688789-48877DBD-D36E-4EB7-A1A1-BDDB7295AE29

Q35688789-662A8417-9835-4AB6-8D4B-50C80A4F3FCB

Q35688789-664F6C49-AB54-4863-94FA-BCA5B7F70021

P304

Q35688789-B7325901-39B3-4BC6-BEC8-07F778275C01

P31

Q35688789-31E4F7E0-F123-4CF1-9277-5FD2114DE903

P356

Q35688789-1CD66B46-D3CC-410F-82B1-205649850C1B

P433

Q35688789-033AE9BF-2F62-43FA-968C-11CD792DFAFF

P478

Q35688789-4936E4EB-93AC-45E3-A9DA-32E07BB903A4

P50

Q35688789-2729A61A-CB5C-40D6-8AB6-D6AAC9B63E19

Q35688789-2767ECE2-9F08-49D0-8553-45515D70BD5B

P577

Q35688789-D07E6491-E10F-4F62-BAAA-158DB3726BA3

P5875

Q35688789-138B5A58-E5A8-4D2C-BD8C-6645EC38ECC9

P698

Q35688789-43CCF1FB-EA22-46E0-A81A-3830DE4C2B8A

P921

Q35688789-2696947D-D7FB-4424-B2EB-85CB831B100B

P932

Q35688789-414BCB1B-428C-4BCF-8FF3-848E972B7604

P356

P1433

P1476

Inducible Toll-like receptor a ...... ession in human adipose tissue

@en

P2093

James L Kirkland

http://www.w3.org/2001/XMLSchema#string

Jane Freedman

http://www.w3.org/2001/XMLSchema#string

Kahraman Tanriverdi

http://www.w3.org/2001/XMLSchema#string

Noyan Gokce

http://www.w3.org/2001/XMLSchema#string

Olga I Vitseva

http://www.w3.org/2001/XMLSchema#string

Tamara T Tchkonia

http://www.w3.org/2001/XMLSchema#string

P2860

Toll-like receptor signalling

A human homologue of the Drosophila Toll protein signals activation of adaptive immunity

Toll to be paid at the gateway to the vessel wall

TLR4 links innate immunity and fatty acid-induced insulin resistance

Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium.

TIR domain-containing adaptors define the specificity of TLR signaling.

Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E

Expression of Toll-like receptors on human platelets.

Regulation of NF-kappaB activation and nuclear translocation by exogenous nitric oxide (NO) donors in TNF-alpha activated vascular endothelial cells.

Role of the Toll-like receptor 4/NF-kappaB pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages.

P304

932-937

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/OBY.2008.25

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

Marie M McDonnell

Caroline M Apovian

P577

2008-02-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5559005

http://www.w3.org/2001/XMLSchema#string

P698

18292749

http://www.w3.org/2001/XMLSchema#string

P921

Toll-like receptor

P932

3264059

http://www.w3.org/2001/XMLSchema#string